Lombard Medical Technologies (LSE:LMT) Tax Provision : £0.35 Mil (TTM As of Dec. 2012)

View and export this data going back to . Start your Free Trial

What is Lombard Medical Technologies Tax Provision?

Lombard Medical Technologies's tax provision for the six months ended in Dec. 2012 was £0.35 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2012 was £0.35 Mil.

Lombard Medical Technologies Tax Provision Historical Data

The historical data trend for Lombard Medical Technologies's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lombard Medical Technologies Tax Provision Chart

Lombard Medical Technologies Annual Data

Trend

Sep02

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Tax Provision

Get a 7-Day Free Trial

1.89

0.99

0.81

1.28

0.35

Lombard Medical Technologies Semi-Annual Data
	Sep02	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12
Tax Provision	Get a 7-Day Free Trial					1.89	0.99	0.81	1.28	0.35

Lombard Medical Technologies Tax Provision Calculation

Tax to be paid.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Tax Provision for the trailing twelve months (TTM) ended in Dec. 2012 was £0.35 Mil.

Lombard Medical Technologies (LSE:LMT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lombard Medical Technologies PLC (LSE:LMT) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lombardmedical.com

Lombard Medical Technologies PLC is engaged in the design and development of endovascular stent grafts, their manufacture, and commercialization either directly through the group's own sales force or through a network of local distributors supported by clinical specialists from Lombard Medical. The principal product, the AorfixT AAA stent graft has European CE mark approval for use in patients with high-angle-neck aneurysms of up to 90 degrees. The group has operations in United Kingdom and United States of America.